Evidence map›Paper›PMID 15632079›Full record

ArticleMolecular and cellular biology2005

The histone chaperone TAF-I/SET/INHAT is required for transcription in vitro of chromatin templates.

Matthew J Gamble, Hediye Erdjument-Bromage, Paul Tempst, Leonard P Freedman, Robert P Fisher

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. The next decade of SET: from an oncoprotein to beyond.Journal of molecular cell biology · 2024
    Review
  3. Article
  4. Article
  5. The SET oncoprotein promotes estrogen-induced transcription by facilitating establishment of active chromatin.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Cracking the ANP32 whips: important functions, unequal requirement, and hints at disease implications.BioEssays : news and reviews in molecular, cellular and developmental biology · 2014
    Article
  15. Regulating Set-β's Subcellular Localization Toggles Its Function between Inhibiting and Promoting Axon Growth and Regeneration.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
    Article
  16. Article
  17. Article
  18. Article
  19. Proteomics analysis of the estrogen receptor alpha receptosome.Molecular & cellular proteomics : MCP · 2010
    Article
  20. Nuclear pore proteins and cancer.Seminars in cell & developmental biology · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Matthew J GambleMolecular Biology Program, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021, USA.
Hediye Erdjument-Bromage
Paul Tempst
Leonard P Freedman
Robert P Fisher
Molecular Biology Consortium · USCornell University · USMemorial Sloan Kettering Cancer Center · US

Funding

MECHANISMS OF GENE CONTROL BY THE VITAMIN D3 RECEPTORR01DK045460 · NIDDK · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI FISHER, ROBERT P · 1992 to 2004
$874k
MECHANISMS OF GENE CONTROL BY THE VITAMIN D3 RECEPTORR37DK045460 · NIDDK · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI FREEDMAN, LEONARD P · 2000 to 2001
$583k
NIDDK NIH HHS DK45460NIDDK NIH HHS R01 DK045460NIDDK NIH HHS R37 DK045460
6 · The paper itself

Abstract

To uncover factors required for transcription by RNA polymerase II on chromatin, we fractionated a mammalian cell nuclear extract. We identified the histone chaperone TAF-I (also known as INHAT [inhibitor of histone acetyltransferase]), which was previously proposed to repress transcription, as a potent activator of chromatin transcription responsive to the vitamin D3 receptor or to Gal4-VP16. TAF-I associates with chromatin in vitro and can substitute for the related protein NAP-1 in assembling chromatin onto cloned DNA templates in cooperation with the remodeling enzyme ATP-dependent chromatin assembly factor (ACF). The chromatin assembly and transcriptional activation functions are distinct, however, and can be dissociated temporally. Efficient transcription of chromatin assembled with TAF-I still requires the presence of TAF-I during the polymerization reaction. Conversely, TAF-I cannot stimulate transcript elongation when added after the other factors necessary for assembly of a preinitiation complex on naked DNA. Thus, TAF-I is required to facilitate transcription at a step after chromatin assembly but before transcript elongation.

Indexed as

Gene Expression RegulationTemplates, GeneticTranscription, GeneticCell FractionationChromatinChromosomal Proteins, Non-HistoneDNA-Binding ProteinsGenes, ReporterHeLa CellsHistone ChaperonesHumansMolecular ChaperonesReceptors, CalcitriolRecombinant Fusion ProteinsRNA Polymerase IITrans-ActivatorsChromatinChromosomal Proteins, Non-HistoneDNA-Binding ProteinsGal-VP16Histone ChaperonesMolecular ChaperonesReceptors, CalcitriolRecombinant Fusion ProteinsRNA Polymerase IISET protein, humanTrans-ActivatorsTranscription Factors

Identifiers

PMID15632079
PMCPMC543418
OpenAlexW2148631084

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.